Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury

XUE Lihui; SONG Hongyu; GAO Qi; LI Shuang; ZHAO Chenlei; BAI Yang; ZHANG Bonan; QI Yajuan

doi:10.13386/j.issn1002-0306.2021050136

Volume 43 Issue 2

Jan. 2022

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(2): 376-383. > DOI: 10.13386/j.issn1002-0306.2021050136

XUE Lihui, SONG Hongyu, GAO Qi, et al. Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury[J]. Science and Technology of Food Industry, 2022, 43(2): 376−383. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021050136.

Citation:

PDF (2551 KB)

Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury

XUE Lihui^1,,
SONG Hongyu¹,
GAO Qi¹,
LI Shuang¹,
ZHAO Chenlei¹,
BAI Yang²,
ZHANG Bonan^{2, 3, 4, ,},
QI Yajuan^{2, 3, 4, ,}

1.
Department of Pharmacy, North China University of Science and Technology, Tangshan 063210, China
2.
School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, China
3.
Tangshan Key Laboratory of New Drug Basic Research, Tangshan 063210, China
4.
Hebei Key Laboratory for Chronic Diseases, Tangshan 063210, China

More Information

Received Date: May 18, 2021
Available Online: November 21, 2021

Graphical Abstract

Abstract

Abstract

Objective: To investigate the protective effect of Baihe Wuyao decoction (BWD) on mice with type 1 diabetes mellitus (T1DM) and liver damage, and to reveal its underlying mechanism. Methods: Ten of 70 mice were randomly selected as the blank group, and the rest were induced with intra-peritoneally (ip) streptozotocin (STZ) to induce T1DM. After successful modeling, the mice were randomly divided into 6 groups: Model group, positive control group and BWD groups (15, 5, 2.5, 1.25 g·kg⁻¹·d⁻¹). The mice in each group were given continuous administration for 6 weeks. The contents of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of mice were measured, and the contents of superoxidedismutase (SOD) and malonaldehyde (MDA) in liver tissue homogenate were detected. The pathological changes of mouse liver were observed. The expression of Protein kinase B (AKT) in mouse liver was detected, the mRNA level of manganese superoxide dismutase (Mn-SOD) and nitric oxide synthase (iNOS), inflammatory factors including tumor necrosis factor (TNF-α), nuclear factor-κB (NF-κB), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), apoptosis factors including B-cell lymphoma-2 (Bcl2), Bcl2-associated X protein (Bax), Caspase 3 (CASP3) were measured. Results: BWD exhibited a good hepatic protection with ameliorating hepatic pathological morphology in T1DM mice. Compared with the model group, the levels of ALT and AST in each dose group were significantly reduced (P<0.01, P<0.05), and the effect of the low 1 dose group was more obvious. The low 1 dose of BWD could significantly up-regulate p-AKT/AKT(P<0.05), low dose 1 could significantly down-regulate MDA, iNOS, and up-regulate SOD and Mn-SOD content(P<0.01, P<0.05). Comparing with the model group, the ratio of Bcl2/Bax at the low dose increased significantly, Bax and CASP3 were down-regulated, the low dose significantly reduced the expression of TNF-α, NF-κB, IL-1β, IL-6 and IL-8 at the gene level (P<0.01, P<0.05). Conclusion: The BWD would have a good hepatic protective effect during T1DM, which underlying mechanisms through improving insulin resistance and suppresses oxidative stress, apoptosis, inflammation and promotion of cell proliferation.
- liver injury,
- inflammation,
- mechanism,
- Baihe Wuyao decoction

FullText(HTML)

References (31)

References

[1]	LIANG T T, ZHANG Q, SUN W X, et al. Zinc treatment prevents type 1 diabetes-induced hepatic oxidative damage, endoplasmic reticulum stress, and cell death, and even prevents possible steatohepatitis in the OVE26 mouse model: Important role of metallothionein[J]. Toxicol Lett,2015,20(2):24−114.
[2]	WANG W P, M JOHN, P KIMBERLY, et al. Hepatoprotective activity of easter lily(Lilium longiflorum Thunb.) bulb extracts[J]. Journal of Agricultural and Food Chemistry,2015,40(44):698−722.
[3]	S VAROL, K SEDAT, S ERHAN, et al. Investigation of endoplasmic reticulum stress and sonic hedgehog pathway in diabetic liver injury in mice[J]. Life Science,2020,10(8):117−156.
[4]	罗良胜, 屈磊磊, 杨丽英, 等. 紫茉莉对高血糖模型小鼠降血糖作用研究[J]. 云南中医中药杂志,2009,30(4):51−53. [LUO L S, QU L L, YANG L Y, et al. Study on hypoglycemic effect of Mirabilis on hyperglycemia model mice[J]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica,2009,30(4):51−53.
[5]	梁燕, 王岳飞, 谢争珍, 等. 茶桑混合袋泡茶降血糖作用的实验研究[J]. 茶叶科学,2008,12(5):358−362. [LIANG Y, WANG Y F, XIE Z Z, et al. Experimental study on hypoglycemic effect of tea-mulberry mixed teabag[J]. Journal of Tea Science,2008,12(5):358−362. doi: 10.3969/j.issn.1000-369X.2008.05.008
[6]	ZHANG H Y, WANG H L, ZHONG G Y, et al. Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury[J]. Pharmaceutical Biology,2018,10(1):594−611.
[7]	田硕, 苗明三, 熊维政, 等. 2020年版《中国药典》(一部)药材和饮片的外用功能及应用分析[J]. 中国实验方剂学杂志,2021,27(8):161−167. [TIAN S, MIAO M S, XIONG W Z, et al. Analysis of the external function and application of medicinal materials and decoction pieces in the 2020 Chinese Pharmacopoeia (Part 1)[J]. Chinese Journal of Experimental Traditional Medical Formulae,2021,27(8):161−167.
[8]	LUO L M, QIN L, ZHAN J H, et al. Study on effects of total saponins from Lilii Bulbus on proliferation, apoptosis, invasion and metastasis of lung cancer cells and its preliminary mechanism[J]. China Journal of Chinese Materia Medica,2018,18(22):4498−4505.
[9]	刘智衡. 百合乌药汤合平胃散加减治疗浅表性胃炎34例临床疗效观察[J]. 中医临床研究,2016,8(8):64−66. [LIU Z H. Clinical observation on 34 cases of superficial gastritis treated with Baihewuyao decoction and Pingwei powder[J]. Clinical Journal of Chinese Medicine,2016,8(8):64−66. doi: 10.3969/j.issn.1674-7860.2016.08.034
[10]	QING L, A J HOON, K S BEOM, et al. Sesquiterpene lactones from the roots of Lindera strychnifolia[J]. Phytochemistry,2012,20(15):89−112.
[11]	SUN X, GAO R L, XIONG Y K, et al. Antitumor and immunomodulatory effects of a water-soluble polysaccharide from Lilii Bulbus in mice[J]. Carbohydrate Polymers,2013,35(18):429−543.
[12]	LUO Y B, LIU M, YAO X J, et al. Total alkaloids from Radix Linderae prevent the production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 cells by suppressing NF-kappaB and MAPKs activation[J]. Cytokine,2009,15(1):100−104.
[13]	邢梦雨, 田崇梅, 夏道宗. 乌药化学成分及药理作用研究进展[J]. 天然产物研究与开发,2017,29(12):2147−2151. [XING Y M, TIAN C M, XIA D Z, et al. Review on chemical constituents and pharmacological effects of Lindera aggregata Kosterm[J]. Nat Prod Res Dev,2017,29(12):2147−2151.
[14]	来伟旗, 朱染枫, 陈建国, 等. 乌药的毒性研究[J]. 职业与健康,2003(12):78−80. [LAI Q W, ZHU R F, CHEN J G, et al. Study on the toxicity of Lindera aggregate (Sims) kosterm[J]. Occupation and Health,2003(12):78−80. doi: 10.3969/j.issn.1004-1257.2003.12.042
[15]	EBTSAM M A, MARWA A A, DOAA H, et al. Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles(LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats[J]. Scientific Reports,2019,9(11):1083−1096.
[16]	WANG J W, CHEN X Y, HU P Y, et al. Effects of Linderae radix extracts on a rat model of alcoholic liver injury[J]. Experimental and Therapeutic Medicine,2016,11(6):2185−2192. doi: 10.3892/etm.2016.3244
[17]	GAN L S, ZHENG Y L, MO J X, et al. Sesquiterpene lactones from the root tubers of Lindera aggregata[J]. Journal of Natural Products,2009,8(8):501−1497.
[18]	CHEN Y J, LI R F, HU N, et al. Baihe Wuyao decoction ameliorates CCl₄-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects[J]. Journal of Ethnopharmacology,2020,23(10):113−227.
[19]	LIM D W, KIM H, LEE S J, et al. Jwa kum whan attenuates nonalcoholic fatty liver disease by modulating glucose metabolism and the insulin signaling pathway[J]. Evidence-Based Complementary and Alternative Medicine,2019:4589810.
[20]	A MAHMOOD, R MOHAMMAD, M EBRAHIM, et al. Urtica dioica and Lamium album decrease glycogen synthase kinase-3 beta and increase K-Ras in diabetic rats[J]. Journal of Pharmacopuncture,2019,14(4):248−252.
[21]	LIU F, ZHANG J, QIAN J, et al. Emodin alleviates CCl4-induced liver fibrosis by suppressing epithelial-mesenchymal transition and transforming growth factor-β1 in rats[J]. Molecular Medicine Reports,2018,18(3):3262−3270.
[22]	B AURÈLE, E JENNIFER L. An intimate relationship between ROS and insulin signalling: Implications for antioxidant treatment of fatty liver disease[J]. International Journal of Cell Biology,2014,15(10):119−153.
[23]	G RAJEEV, S MONIL, F ABUL FAIZ. Glutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress[J]. Journal of Mid-Life Health,2011,8(2):6−72.
[24]	LIU W, JING Z T, XUE C R, et al. PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injury[J]. Toxicology and Applied Pharmacology,2019,19(10):714−729.
[25]	LIU Y E, TONG C C, TANG Y S, et al. Tanshinone IIA alleviates blast-induced inflammation, oxidative stress and apoptosis in mice partly by inhibiting the PI3K/AKT/FoxO1 signaling pathway[J]. Free Radical Biology & Medicine,2020,23(18):52−60.
[26]	R FARZAD, A FERESHTEH, A AMIR, et al. Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways[J]. Life Science,2020,15(6):117−150.
[27]	J Y KIM MULLER, Y J R KIM, J FAN, et al. FoxO1 deacetylation decreases fatty acid oxidation in β-cells and sustains insulin secretion in diabetes[J]. The Journal of Biological Chemistry,2016,21(19):72−101.
[28]	T MOLDOVEANU, P E CZABOTAR. BAX, BAK, and BOK: A coming of age for the BCL-2 family effector proteins[J]. Cold Spring Harbor Perspectives in Biology,2020,12(4):56−60.
[29]	E FRANK. BCL-2 proteins and apoptosis: Recent insights and unknowns[J]. Biochemical and Biophysical Research Communications,2018,500(1):26−34. doi: 10.1016/j.bbrc.2017.06.190
[30]	AG PORTER, R U JÄNICKE. Emerging roles of caspase-3 in apoptosis[J]. Cell Death and Differentiation,1999,6(2):99−104. doi: 10.1038/sj.cdd.4400476
[31]	M LÉVEILLÉ, ESTALL J L. Mitochondrial dysfunction in the transition from NASH to HCC[J]. Metabolites,2019,9(10):233. doi: 10.3390/metabo9100233

[1]	GAO Xueli, GU Qianqian, LI Guanghui, WANG Yonghui, HE Shenghua, HUANG Jihong, GUO Weiyun. Optimization of the Formulation and Process of Sweet Potato Leaf Jelly by Response Surface Methodology[J]. Science and Technology of Food Industry, 2023, 44(18): 276-282. DOI: 10.13386/j.issn1002-0306.2022110222
[2]	CAO Geng, WEN Chengrong, CHEN Xueting, HU Bingbing. Optimization of the Formula of Potato Steamed Bread[J]. Science and Technology of Food Industry, 2022, 43(14): 178-184. DOI: 10.13386/j.issn1002-0306.2021090330
[3]	TAO Wen-bin, WU Yan-yan, LI Chun-sheng, YANG Xian-qing, LIN Wan-ling, RONG Hui. Optimization of Low-sodium Compound Salty Agent Formula for Pickled Larimichthys crocea Fillets by Response Surface Methodology[J]. Science and Technology of Food Industry, 2019, 40(19): 136-144. DOI: 10.13386/j.issn1002-0306.2019.19.023
[4]	ZHANG Ling-wen, WANG Xue-fei, LI Sha-sha, JI Hong-fang, BI Ji-cai, MA Han-jun. Optimization of Formula of Non-fermented Quick-frozen Deep-fried Dough Sticks by Response Surface Analysis[J]. Science and Technology of Food Industry, 2019, 40(7): 190-198. DOI: 10.13386/j.issn1002-0306.2019.07.033
[5]	ZHANG Ya-na, GUO li, CHAI Yun-lei, XIA Tong, LI Xu-ke. Formula Optimization of Blueberry Pomace Dietary Fiber Cake[J]. Science and Technology of Food Industry, 2018, 39(24): 222-226,233. DOI: 10.13386/j.issn1002-0306.2018.24.038
[6]	ZHANG Zhi-cheng, ZHOU Huan, ZHENG Xiao-jie, YUAN Ling, LI Yan-po, XU Qian. Formula optimization of biscuits with Cyclocarya paliurus leaves[J]. Science and Technology of Food Industry, 2018, 39(7): 152-157. DOI: 10.13386/j.issn1002-0306.2018.07.028
[7]	LIU Ru-cui, DU Cai-xia, WANG Di, JANG Pan, LIAN Feng, LIU Jun. Formula optimization of inactive double protein Lactobacillus beverage[J]. Science and Technology of Food Industry, 2018, 39(3): 183-186. DOI: 10.13386/j.issn1002-0306.2018.03.036
[8]	TONG Xiao-meng, CHAI Chun-xiang. Optimization of formula of soybean buckwheat solid beverage[J]. Science and Technology of Food Industry, 2018, 39(1): 177-182. DOI: 10.13386/j.issn1002-0306.2018.01.033
[9]	SHAN Lian-gang, LI Hong-tao, MA Lin. Optimization of formula of sponge cake with xylitol and purple sweet potato[J]. Science and Technology of Food Industry, 2016, (16): 296-301. DOI: 10.13386/j.issn1002-0306.2016.16.050
[10]	ZHAO Jian-jun, HAN Jun-qi, ZHANG Run-guang, FENG Bin-kui, MA Yu-juan, WANG Xiao-ji, ZHANG You-lin. Study on the technology and formula of preparing relish instant walnut powder[J]. Science and Technology of Food Industry, 2014, (14): 272-277. DOI: 10.13386/j.issn1002-0306.2014.14.052

Supplements (0)

Cited By

Cited by

Periodical cited type(17)

1.	胡一杰，刘杏宜，刘剑，邝金文，徐中岳. 我国保健食品功能声称存在的问题及发展对策研究. 卫生软科学. 2025(03): 49-53 .
2.	杨帅，郑林，迟明艳，巩仔鹏，李月婷，魏茂陈，黄勇. UPLC-MS/MS法同时测定阿胶中18种核苷、游离氨基酸的含量. 中成药. 2024(07): 2140-2146 .
3.	蒲健，杨帅，祝扬帆，谭丹，郑林，迟明艳，黄勇. UPLC-MS/MS法同时测定阿胶中20种氨基酸含量及其化学模式识别分析. 中国药业. 2024(22): 87-94 .
4.	云振宇，吴琦，兰韬，赵琳，周紫梦. 基于高质量发展的我国保健食品标准化工作现状、问题分析及展望. 食品工业科技. 2023(08): 476-484 . 本站查看
5.	陈建平，何颂捷，谢皓玥，胡凤，谭文渊. 超高效液相色谱-三重四级杆质谱法测定保健食品中六种功能成分. 食品与发酵科技. 2023(02): 124-130 .
6.	陶瑞，刘晨晨，王远远，刘柱. 保健食品检测技术指导原则解读及发展方向探讨. 食品安全质量检测学报. 2023(14): 166-174 .
7.	王超，张潇予，祝波，杨钊. 高效液相色谱-串联四级杆质谱法测定保健食品中氯化高铁血红素. 中国食品添加剂. 2023(11): 197-201 .
8.	史敏. 保健食品功效成分检测技术与方法. 食品安全导刊. 2023(32): 166-168 .
9.	姜雨，李菲菲，付雨，李雨虹，尹秀文. 辅酶Q10类保健食品注册审评审批状况分析与建议. 食品工业科技. 2022(08): 264-272 . 本站查看
10.	魏素珍. 具有保护肺功能的保健食品功能学检测方法研究. 中国食品工业. 2022(07): 118-121 .
11.	袁利杰，纵伟. 超高效液相色谱-四极杆/轨道阱高分辨质谱法快速筛查功能性保健食品中19种特征性成分. 食品安全质量检测学报. 2022(20): 6518-6527 .
12.	陈建平，冉渺，谢皓玥，田富丽. 超高效液相质谱法测定增强免疫类中药保健食品中多种功能成分含量. 中药与临床. 2022(06): 29-33 .
13.	张再平，吴莉，方方，冯有龙，曹玲. 超高效液相色谱法同时测定芦荟保健食品中8种蒽醌类成分的含量. 食品科技. 2021(04): 291-295 .
14.	田明，孙璐，李昱霏，胡昊，冯军. 基于国际经验探究中国保健食品原料管理研究. 食品工业科技. 2021(13): 21-25 . 本站查看
15.	田明，尹淑涛，闫志刚，薛天. 澳大利亚补充药品管理及对我国保健食品监管启示研究. 食品安全质量检测学报. 2021(11): 4438-4445 .
16.	王倩，刘睿，朱悦，杨滨，丁玉华，白加德，温华军，吴海荣，段金廒，赵明. 麋鹿角中核苷类和氨基酸类成分区域差异性分析. 中国中药杂志. 2021(14): 3494-3503 .
17.	袁利杰. 河南省2018年—2020年保健食品抽检结果分析. 中国卫生检验杂志. 2021(23): 2909-2913 .

Other cited types(6)

Get Citation

PDF

XML

Article Metrics

Article views (225) PDF downloads (19) Cited by(23)

Science and Technology of Food Industry

Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury